Medium/long term effect of travoprost on the intraocular pressure (IOP) in normal tension glaucoma (NTG)
| ISRCTN | ISRCTN53835788 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN53835788 |
| Secondary identifying numbers | N0547147995 |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 03/06/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr G.S. Ang
Scientific
Scientific
Senior House Officer
Department of Ophthalmology
Norfolk and Norwich University Hospital NHS Trust
Colney
Norwich
NR4 7UY
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Treatment |
| Scientific title | |
| Study objectives | Travoprost is a new prostaglandin analogue recently approved for treatment of ocular hypertension and glaucoma. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Eye Diseases: Glaucoma |
| Intervention | Prospective randomised controlled observer blinded clinical trial. |
| Intervention type | Other |
| Primary outcome measure | The primary clinical outcome measure is diurnal IOP at follow up phasing: the major comparison is to be made between the IOP for travoprost treatment group and for the non-treatment group. |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/04/2004 |
| Completion date | 01/06/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Not Specified |
| Target number of participants | 25-30 patients |
| Key inclusion criteria | Adults with normal tension glaucoma. |
| Key exclusion criteria | 1. Patients on systemic medication 2. Patients who have undergone intraocular eye surgery |
| Date of first enrolment | 01/04/2004 |
| Date of final enrolment | 01/06/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Senior House Officer
Norwich
NR4 7UY
United Kingdom
NR4 7UY
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Phone | +44 (0)20 7307 2622 |
|---|---|
| dhmail@doh.gsi.org.uk | |
| Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
East Norfolk and Waveney Research Consortium - Norfolk and Norwich University Hospital/Norwich PCT
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 01/08/2008 | Yes | No |
